Xlife Sciences AG / Key word(s): Letter of Intent/PartnershipXlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases 20.12.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) and Quant Biomar.
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Xlife Sciences AG / Key word(s): Miscellaneous/Regulatory Approval16-Feb-2023 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Medical Screening Device Set to Measure Complex Neurocognitive Performance for Early Detection of.
Xlife Sciences AG / Key word(s): PatentXlife Sciences: Swiss portfolio company Axenoll receives strategically significant patent by the European Patent OfficeTitle 20.01.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) announced today that its Swiss portfolio company Axenoll Life Sciences AG has been granted a stra.
Xlife Sciences AG / Key word(s): MiscellaneousXlife Sciences portfolio company launches project to research a potential therapy for amyotrophic lateral sclerosis (ALS) 16.01.2023 / 07:00 CET/CESTXlife Sciences' (SIX: XLS) portfolio company inflamed pharma has launched a research project to develop a potential th.